Selective estrogen receptor modulators for BPH: new factors on the ground. (Q38115066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

title

Selective estrogen receptor modulators for BPH: new factors on the ground (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

author name string

M Garg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

D Dalela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

D Dalela

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

M Kumar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

G Gupta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

S N Sankhwar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

publication date

18 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

226-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

The induction of prostatic hypertrophy in the dog with androstanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Comparison of spontaneous and experimentally induced canine prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Nuclear receptor coactivators and corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen-regulated development and differentiation of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor β ligands: recent advances and biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Potential risks and benefits of phytoestrogen-rich diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

The role of estrogens and estrogen receptors in normal prostate growth and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Aetiology and pathogenesis of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Molecular and cellular pathogenesis of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Stromal-epithelial interactions in the normal and neoplastic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

The pathogenesis of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen and androgen signaling in the pathogenesis of BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Selectively targeting estrogen receptors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen signaling: a subtle balance between ER alpha and ER beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen receptor beta in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Generation of red fluorescent protein transgenic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Effect of tamoxifen citrate on reproductive parameters of male dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Comparison of the effect of the aromatase inhibitor, anastrazole, to the antioestrogen, tamoxifen citrate, on canine prostate and semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estradiol in elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Natural history of human prostate gland: Morphometric and histopathological analysis of Japanese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Treating prostate cancer: a rationale for targeting local oestrogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Cell localization, physiology, and nongenomic actions of estrogen receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

Etiology and disease process of benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2013.17

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/PCAN.2013.17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23774084 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference